Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Tc Biopharm [Holdings] Plc WT (TCBPW)

Tc Biopharm [Holdings] Plc WT (TCBPW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
TC BioPharm Announces New Chair of the Board, Arlene Morris PR Newswire - Tue Feb 14, 2023

/PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)
TC BioPharm to Reschedule Shareholder Update Call and Webcast PR Newswire - Mon Feb 13, 2023

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)
TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division PR Newswire - Mon Jan 30, 2023

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)
TC BioPharm to Host Shareholder Update Call PR Newswire - Fri Jan 20, 2023

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials FinancialNewsMedia - Thu Jan 19, 2023

EQNX::TICKER_START (NASDAQ:TCBP),(NASDAQ:CRDF),(NASDAQ:CYAD),(NASDAQ:RIGL),(NASDAQ:AZN) EQNX::TICKER_END

TCBPW : 0.0060 (-38.14%)
AZN : 208.45 (+2.19%)
CYAD : 0.4700 (-11.10%)
TCBP : 0.5000 (-67.53%)
RIGL : 34.74 (-2.72%)
CRDF : 1.9400 (-1.02%)
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology FinancialNewsMedia - Thu Jan 19, 2023

EQNX::TICKER_START (NASDAQ:TCBP) EQNX::TICKER_END

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology PR Newswire - Tue Jan 17, 2023

/PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)
TC BioPharm Announces Closing of $7.35 Million Private Placement PR Newswire - Wed Nov 30, 2022

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (Nasdaq: TCBP) (Nasdaq: TCBPW), a clinical stage biotechnology company developing...

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)
TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid Leukemia PR Newswire - Tue Nov 22, 2022

/PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)
TC BioPharm to Present at Upcoming Investor Conferences PR Newswire - Mon Oct 3, 2022

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing...

TCBPW : 0.0060 (-38.14%)
TCBP : 0.5000 (-67.53%)

Barchart Exclusives

Citi Analysts Like This 1 ‘Picks-and-Shovels’ AI Stock. Should You Buy It Here? Barchart - Sat Feb 28, 10:30AM CST
This multibagger AI stock has received a "Buy" rating and price upgrade from a Citi analyst with strong support on Wall Street. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot